Recombinant TFPI-2 enhances macrophage apoptosis through upregulation of Fas/FasL

European Journal of Pharmacology

Volumn 654, Issue 2, 2011, Pages 135-141

  Pan, Jun Jie ^a   Shi, Hai Ming ^a   Luo, Xin Ping ^a,b   Ma, Duan ^b   Li, Yong ^a   Zhu, Jun ^a   Liang, Wang ^b   Mu, Jin Gui ^b   Li, Jian ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Atherosclerosis; Caspase 8; Fas FasL; Tissue factor pathway inhibitor 2

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DNA FRAGMENT; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; PROCASPASE 8; RECOMBINANT PLACENTA PROTEIN 5; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIGENS, CD95; APOPTOSIS; BENZIMIDAZOLES; CASPASES; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FLUORESCENT DYES; GLYCOPROTEINS; HUMANS; MACROPHAGES; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; U937 CELLS; UP-REGULATION;

EID: 79551581432     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.12.015     Document Type: Article

References (29)

1. S. Arai, J.M. Shelton, M. Chen, M.N. Bradley, A. Castrillo, A.L. Bookout, P.A. Mak, P.A. Edwards, D.J. Mangelsdorf, P. Tontonoz, and T. Miyazaki A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development Cell Metab. 1 2005 201 213
2. A. Bhattacharyya, S. Pathak, C. Basak, S. Law, M. Kundu, and J. Basu Execution of macrophage apoptosis by Mycobacterium avium through apoptosis signal-regulating kinase 1/p38 mitogen-activated protein kinase signaling and caspase 8 activation J. Biol. Chem. 278 2003 26517 26525
3. -/- mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 1998 894 897
4. R. Butzow, M.L. Huhtala, H. Bohn, I. Virtanen, and M. Seppala Purification and characterization of placental protein 5 Biochem. Biophys. Res. Commun. 150 1988 483 490
5. V.A. Fadok, D.L. Bratton, A. Konowal, P.W. Freed, J.Y. Westcott, and P.M. Henson Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF J. Clin. Invest. 101 1998 890 898
6. J. George, C.S. Gondi, D.H. Dinh, M. Gujrati, and J.S. Rao Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis Clin. Cancer Res. 13 2007 3507 3517
7. C.K. Glass, and J.L. Witztum Atherosclerosis: the road ahead Cell 104 2001 513 516
8. L. Gu, Y. Okada, S.K. Clinton, C. Gerard, G.K. Sukhova, P. Libby, and B.J. Rollins Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Mol. Cell 2 1998 275 281
9. M.P. Herman, G.K. Sukhova, W. Kisiel, D. Foster, M.R. Kehry, P. Libby, and U. Schonbeck Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis J. Clin. Invest. 107 2001 1117 1126
10. M. Iino, D.C. Foster, and W. Kisiel Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2 Arterioscler. Thromb. Vasc. Biol. 18 1998 40 46
11. L. Ivanciu, R.D. Gerard, H. Tang, F. Lupu, and C. Lupu Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis Arterioscler. Thromb. Vasc. Biol. 27 2007 310 316
12. F.C. Kischkel, S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P.H. Krammer, and M.E. Peter Cytotoxicity-dependent APO-1(Fas/CD95)-associated proteins form a death-inducing signaling complex(DISC) with the receptor EMBO J. 10 1995 5579 5588
13. M.M. Kockx, and A.G. Herman Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc. Res. 45 2000 736 746
14. D. Kong, D. Ma, H. Bai, H. Guo, X. Cai, W. Mo, Q. Tang, and H. Song Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2 Biochem. Biophys. Res. Commun. 324 2004 1179 1185
15. H. Li, and J. Yuan Deciphering the pathways of life and death Curr. Opin. Cell Biol. 11 1999 261 266
16. J. Liu, D.P. Thewke, Y.R. Su, M.F. Linton, S. Fazio, and M.S. Sinensky Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice Arterioscler. Thromb. Vasc. Biol. 25 2005 174 179
17. W.H. Liu, Y.C. Cheng, and L.S. Chang ROS-mediated p38a MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A2-treated U937 cells J. Cell. Physiol. 219 2009 642 651
18. V. Neaud, T. Hisaka, A. Monvoisin, C. Bedin, C. Balabaud, D.C. Foster, A. Desmouliere, W. Kisiel, and J. Rosenbaum Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells J. Biol. Chem. 275 2000 35565 35569
19. L.C. Petersen, C.A. Sprecher, D.C. Foster, H. Blumberg, T. Hamamoto, and W. Kisiel Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor Biochemistry 35 1996 266 272
20. K. Schulze-Osthoff, D. Ferrari, M. Los, S. Wesselborg, and M.E. Peter Apoptosis signaling by death receptors Eur. J. Biochem. 254 1998 439 454
21. E. Shinoda, Y. Yui, R. Hattori, M. Tanaka, R. Inoue, T. Aoyama, Y. Takimoto, Y. Mitsui, K. Iyahara, Y. Shizuta, and S. Sasayama Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells J. Biol. Chem. 274 1999 5379 5384
22. J.D. Smith, E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E Proc. Natl. Acad. Sci. U.S.A. 92 1995 8264 8268
23. C.A. Sprecher, W. Kisiel, S. Mathewes, and D.C. Foster Molecular cloning, expression, and partial characterization of a second human tissue-factor pathway inhibitor Proc. Natl. Acad. Sci. U.S.A. 91 1994 3353 3357
24. D. Steinberg Lipoproteins and atherosclerosis. A look back and a look ahead Arteriosclerosis 3 1983 283 301
25. I. Tabas Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis the importance of lesion stage and phagocytic efficiency Arterioscler. Thromb. Vasc. Biol. 25 2005 2255 2264
26. K. Udagawa, Y. Miyagi, F. Hirahara, E. Miyagi, Y. Nagashima, H. Minaguchi, K. Misugi, H. Yasumitsu, and K. Miyazaki Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization Placenta 19 1998 217 223
27. H. Wajant CD95L/FasL and TRAIL in tumour surveillance and cancer therapy Cancer Treat. Res. 130 2006 141 145
28. Z.B. Wang, Y.Q. Liu, and Y.F. Cui Pathways to caspase activation Cell Biol. Int. 29 2005 489 496
29. Z. Xu, D. Maiti, W. Kisiel, and E.J. Duh Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells Arterioscler. Thromb. Vasc. Biol. 26 2006 2819 2825